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Much attention has focused on a small set of tran-
scription factors that maintain human or mouse
embryonic stem (ES) cells in a pluripotent state. To
gain a more complete understanding of the regula-
tory network that maintains this state, we identified
target promoters of nine transcription factors, includ-
ing somatic cell reprogramming factors (Oct4, Sox2,
Klf4, and c-Myc) and others (Nanog, Dax1, Rex1,
Zpf281, and Nac1), on a global scale in mouse ES
cells.We found that target genes fall into two classes:
promoters bound by few factors tend to be inactive
or repressed, whereas promoters bound by more
than four factors are largely active in the pluripotent
state and become repressed upon differentiation.
Furthermore, we propose a transcriptional hierarchy
for reprogramming factors and broadly distinguish
targets of c-Myc versus other factors. Our data
provide a resource for exploration of the complex
network maintaining pluripotency.
INTRODUCTION
Pluripotency, the capacity to generate all cell types, is a defining
property of embryonic stem (ES) cells, cultured cells derived
from the inner cell mass of the mammalian blastocyst (Evans
and Kaufman, 1981; Martin, 1981). In addition, ES cells can be
maintained in a proliferative state for prolonged periods, the
phenomenon of self-renewal. Pluripotency may be imposed on
somatic cells following their fusion with ES cells (Cowan et al.,
2005), and one transcription factor specifically expressed in ES
cells, Nanog, facilitates fusion-induced pluripotency (Silva
et al., 2006). Moreover, forced expression of other transcriptional
factors (Oct4, Sox2, Klf4, and c-Myc) reprograms mouse fibro-
blasts to ES-like cells (called iPS cells)(Takahashi and Yama-
naka, 2006), the quality of which is enhanced upon selection of
cells that express endogenous Oct4 or Nanog (Maherali et al.,
2007; Okita et al., 2007; Wernig et al., 2007b). Recently, it has
been shown that the same factors reprogram human fibroblaststo a pluripotent state (Park et al., 2007; Takahashi et al., 2007; Yu
et al., 2007). How pluripotency is established and maintained in
ES cells is of great interest, as an improved understanding of the
transcription factors and epigenetic modifications operating in
a regulatory network will facilitate both directed programming
of ES cells to specific lineages and the reprogramming of
somatic cells to an ES-like state.
Until recently, attention has focused almost exclusively on
a small set of transcription factors, Oct4, Sox2, and Nanog as
‘‘core’’ pluripotency factors for human or mouse ES cells (Orkin,
2005). Oct4 has long been recognized to be essential in vivo and
in vitro for early development and maintenance of pluripotency
(Nichols et al., 1998). Indeed, the dosage of Oct4 is crucial:
reduced expression permit trophoectoderm development,
whereas enhanced expression drives primitive endoderm differ-
entiation (Niwa et al., 2000). Sox2 is a transcriptional partner of
Oct4 (Avilion et al., 2003). Rather than directly interacting with
Oct4 protein, Sox2 assembles on target regulatory elements
with Oct4 to collaborate in transcriptional control. Nanog
promotes ES cell self-renewal and alleviates the requirement
for Leukemia Inhibitory Factor (LIF) (Chambers et al., 2003;
Mitsui et al., 2003). While considerable evidence speaks to the
importance of these factors in maintaining the properties of ES
cells, evidence also points to the involvement of additional
transcription factors in the control of pluripotency (Ivanova
et al., 2006; Wang et al., 2006; Zhou et al., 2007).
To account for the unique properties of pluripotent ES or iPS
cells at the molecular level, it will be necessary to understand
the transcriptional networks responsible for maintaining pluripo-
tency. Studies to this end have entailed the search for additional
transcription factors and delineation of a protein-protein interac-
tion network highly enriched for factors involved in the control of
pluripotency (Ivanova et al., 2006; Wang et al., 2006), and prelim-
inary global target gene assessment for the initial core factors
(Boyer et al., 2005; Loh et al., 2006). Starting with the identifica-
tion of protein partners of Nanog through protein complexes
purification and microsequencing, coupled with iterative affinity
purification of interacting proteins, we generated a network
that includes additional factors required for maintenance of
pluripotency (Wang et al., 2006). Among this latter class, we
encountered Sall4 (Sakaki-Yumoto et al., 2006; Wu et al.,
2006; Zhang et al., 2006), Dax1 (Niakan et al., 2006), and Rif1Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc. 1049
(Loh et al., 2006), factors identified independently by others as
involved in maintenance of ES cell pluripotency. The protein
network is connected to complexes, such as NuRD remodeling
complex and PRC1, implicated in transcriptional repression
(Wang et al., 2006). In parallel, other groups have used new
methods for global target mapping (ChIP-Chip and ChIP-PET)
to predicted target genes regulated by Oct4, Sox2, and Nanog
in mouse and human ES cells. These studies revealed combina-
torial occupancy of target gene promoters by these core factors
and both autoregulatory and feed-forward transcriptional cir-
cuits (Boyer et al., 2005; Loh et al., 2006). The discovery of
a 4-factor reprogramming set (Takahashi and Yamanaka,
2006) identified Klf4 and c-Myc as additional proteins to be
integrated into the network inducing and/or maintaining pluripo-
tency. In parallel, other work has suggested that histone modifi-
cation signatures, specifically histone 3 lysine 4 and histone 3 ly-
sine 27 trimethylation (H3K4me3 and H3K27me3, respectively),
are important in controlling gene regulation in ES cells (Bernstein
et al., 2006; Boyer et al., 2006; Lee et al., 2006; Pan et al., 2007;
Zhao et al., 2007).
Genome-wide mapping of transcription factor targets by ChIP,
combined with microarrays or sequencing methods, is a power-
ful tool for laying a foundation for understanding transcriptional
networks (Iyer et al., 2001; Kim et al., 2005; Loh et al., 2006;
Ren et al., 2000; Roh et al., 2004). Expanding the number of
transcription factors analyzed by ChIP-based methods should
be especially informative in dissecting system level biological
processes, as 10% of annotated mammalian genes are pre-
dicted to encode DNA-binding proteins (Messina et al., 2004).
A practical limitation to current ChIP approaches is the availability
of suitable ‘‘ChIP quality’’ antibodies.
We report the application of in vivo biotinylation mediated
ChIP (bioChIP) to global target mapping (bioChIP-Chip) of an ex-
panded set of factors associated with pluripotency of mES cells
(Mito et al., 2005). This approach, which relies on streptavidin af-
finity capture of tagged proteins, is comparable to conventional
ChIP-Chip but circumvents issues related to antibody availabil-
ity. Using bioChIP-Chip, we have identified target promoters of
nine transcription factors, including the somatic cell reprogram-
ming factors, on a global scale. We have constructed an
expanded transcriptional regulatory network containing the pre-
viously known three core factors, as well as additional factors.
Our data argue that differential regulation of target genes corre-
lates with the extent of promoter occupancy by multiple factors.
Moreover, we propose a transcriptional hierarchy for the somatic
reprogramming factors and broadly distinguish targets of c-Myc
versus the other factors. Our data provides a resource with
which to probe mechanisms of pluripotency control and differen-
tiation by the complex transcriptional regulatory network in ES or
iPS cells.
RESULTS
Global Mapping of Target Genes by Biotin-Mediated
Chromatin Immunoprecipitation
Prior genome-wide chromatin immunoprecipitation (ChIP) anal-
yses relying on antibodies have been performed in mouse and
human ES cells with core factors (Oct4, Sox2, and Nanog)1050 Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc.involved in maintaining pluripotency. Our first goal was to define
the targets of a larger set of pluripotency factors with greater
consistency in the experimental platform. To this end, we
assessed the suitability of streptavidin affinity-capture of
in vivo biotin-tagging of proteins (de Boer et al., 2003; Wang
et al., 2006) as an alternative to antibody-based ChIP.
Earlier studies proposed application of the biotin-tagging
method for ChIP assay (de Boer et al., 2003), and showed its
utility in combination with Drosophila microarrays (Mito et al.,
2005, 2007). However, the feasibility of bioChIP-chip in complex
mammalian genomes has not been explored (Figure 1A and
Experimental Procedures). We performed bioChIP and conven-
tional ChIP reactions in mES cells for both Nanog and c-Myc
(Myc). bioChIP and ChIP samples were hybridized onto Affyme-
trix mouse promoter arrays with appropriate references to map
the target loci of each factor. We compared targets predicted
by the two methods for both factors. The majority of targets
predicted for each factor by the two methods were shared.
67% and 81% of bioChIP targets of Nanog and Myc, respec-
tively, were identified with the conventional ChIP approach
(Figures 1C and 1D). The overall shapes of binding peaks of
Nanog and Myc across the genome were nearly identical for
the two methods (Figure S1 available online). The correlation of
target loci from the two different methods was 0.896 for Nanog
(Figure S3, see Experimental Procedures), suggesting that
bioChIP is comparable to conventional antibody ChIP.
On comparison with previously published mES ChIP-PET data
(Loh et al., 2006), we observed 60% overlap in promoter
targets (58% and 65% of ChIP-PET targets were also defined
as bioNanog and Nanog antibodyChIP-chip targets, respec-
tively). However, given that ChIP-PET predicted only 434
promoter targets (337 comparable RefSeq promoters) for Nanog
in contrast to our ChIP data (1284 bioChIP targets and 1742 con-
ventional ChIP targets, Figure 1C), we asked whether the lower
number reflects partial coverage, perhaps due to the depth of
sequencing and/or tiling array repeat masking. We tested con-
ventional antibody ChIP material on one of the seven Affymetrix
whole genome mouse arrays (Mouse Tiling 2.0R F Array) that
covers15% of the entire genome and 14% of well annotated
genes and found 223 promoter targets (R 50% number of ChIP-
PET promoter targets) with a similar proportion of nonpromoter
targets as predicted by ChIP-PET (12.8%). In addition, we iden-
tified 137 genes in common in our bioChIP and published human
Nanog ChIP data that are not represented in ChIP-PET (Table
S3)(Boyer et al., 2005; Loh et al., 2006). Taken together, these
data imply that the ChIP-PET data set may lack targets due to
inadequate depth of sequencing (Euskirchen et al., 2007).
We proceeded to determine the global target promoters for
nine transcription factors in ES cells, including previously exam-
ined core factors (Nanog, Oct4, and Sox2)(Boyer et al., 2005; Loh
et al., 2006), somatic cell reprogramming factors (Klf4 and Myc,
in addition to Oct4 and Sox2) (Maherali et al., 2007; Okita et al.,
2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007b), and
protein-interacting partners of Nanog and Oct4 (Dax1, Nac1,
Zfp281 and Rex1) (Wang et al., 2006). In each instance, we
employed cells expressing a subendogenous level of the respec-
tive biotin-tagged factor, so as to avoid perturbing the existing
network (Figure S2). The levels at which exogeneous proteins
Figure 1. Strategy of In Vivo Biotinylation-Mediated Chromatin Immunoprecipitation and Microarray
(A) Schematic representation of biotin-mediated chromatin immunoprecipitation. The gray bar represents BirA target sequence (MSGLNDIFEAQKIEWHE-
GAPSSR).
(B) Expression analysis of nine genes using cell lines expressing biotin-tagged proteins. Biotin-tagged cell lines are indicated on the horizontal axis and transcript
levels are presented as color bars. Error bars represent standard deviation from three independent repeats.
(C and D) Overlap of target promoters between bioChIP-chip and conventional ChIP-chip experiments for Nanog (C) and Myc (D). Predicted overlap may be
underestimated due to a fixed statistical threshold (see Figures 2 and S3).were expressed fail to elicit subsequent change in the transcript
levels of the nine factors (Figure 1B) (Wang et al., 2006).
Before analyzing global targets, we performed additional
validation experiments to assess whether low expression of a
biotin-tagged protein might perturb chromatin occupancy by
untagged proteins. Accordingly, we performed conventional
Nanog antibody ChIP reactions using wild-type mES cells,
mES cells expressing BirA alone, and mES cells expressing
BirA plus tagged versions of Dax1, Oct4, and Nanog. Figure 2
shows that the overall patterns of Nanog binding peaks among
these different cell lines are indistinguishable. Target correla-
tions across the cell lines were also very strong (most were >
0.960 and the correlation between bioChIP data and antibodyChIP data across multiple cells is > 0.880, Figure S3). These
data exclude significant effects of subendogenous levels of
expressed protein on factor occupancy. To exclude artifacts
due to biotinylation of endogeneous proteins by expressed
BirA, we performed ChIP-chip using BirA expressing cells with
input genomic DNA as a reference (Figure 2). We observed
only 18 specific peaks among all promoter regions. Thus, non-
specific effects due to biotinlyation of endogenous DNA-binding
proteins are insignificant compared with the number of targets
for each factor (>500).
Taken together, our findings demonstrate that the bioChIP-
chip method is a valid alternative to the conventional
ChIP-chip method.Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc. 1051
Figure 2. Chromosomal View of Nanog Occupancy Detected by bioChIP-Chip and Conventional ChIP-Chip
(A) Comparison of Nanog binding patterns using multiple cell lines is displayed using Affymetrix Integrated Genome Browser. In addition to bioNanog ChIP (top),
antibody ChIP-chip data from control cell lines (J1 ES and BirA expressing cells) and cells expressing ectopic biotin-tagged protein (bioNanog, bioDax1 and bio-
Oct4 cells) are tested. Nonspecific biotinylation by BirA enzyme was also tested (bottom). Yellow box indicates the chromosomal loci harboring Gbx2.
(B) Representative view of Nanog occupancy at the Gbx2 upstream promoter.Promoter Occupancy of Nine Transcription
Factors in mES Cells
In addition to the nine transcription factors noted above, we map-
ped two histone modifications, H3K4me3 and H3K27me3, by
antibody ChIP-chip. Information from 8 kb upstream and 2 kb
downstream of 19,253 well-characterized transcription start site
(TSS) of RefSeq genes from UCSC genome browser was used
for analysis (see Experimental Procedures) (Kuhn et al., 2007).
The number of target promoters occupied by each factor is
shown in Figure 3A. A compilation of target genes for each factor
and binding peak positions are provided in Table S1 and Table
S2, respectively. As expected, the number of targets occupied
by the different factors varies greatly (Figure 3A). Notably, Myc
occupies many more target promoters (18% of all promoters)
than the other factors. This result is in accordance with prior
observations in other cell types (Fernandez et al., 2003; Li
et al., 2003; Mao et al., 2003). We also found that approximately
50% and 10% of promoters bear H3K4me3 and H3K27me3
marks, respectively (discussed below). We observed that the
vast majority of binding sites for each factor were in close prox-
imity to the TSS (Figure 3B), and more than a third of mouse pro-
moters were occupied by at least one of the nine transcription
factors we tested (6632 promoters, Figure 3C).
A previous study of hES cells showed that Nanog, Oct4, and
Sox2 share many targets (353 genes) (Boyer et al., 2005). Sur-
prisingly, our bioChIP-chip data reveal that many more pro-
moters are co-occupied by multiple factors. We have observed
that > 100 promoters are occupied by at least seven factors,
and 800 promoters are occupied by at least four of the nine
factors examined (Figure 3C). More interestingly, actual binding1052 Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc.loci of multiple factors within the target promoters are virtually
coincident, suggesting that factors work as protein complexes
or within compact cis-regulatory elements when multiple factors
occupy the same target locus (Figure S4). We also observed
numerous target loci occupied by fewer factors (Figure S4). To
define a consensus motif that might be utilized by the multiple
factors, we tested ± 100bp genomic sequence information
from the center position of predicted common target loci using
MEME (Bailey et al., 2006). Interestingly the consensus motif
(ATTTGCAT) predicted from MEME (e-value 1.4E-50, Figure 3D)
was similar to sequences previously predicted by different algo-
rithms as Oct4 or Sox2-Oct4 target sequences (Loh et al., 2006;
Macisaac et al., 2006). Targets in common among our data,
human ChIP-Chip data (Boyer et al., 2006), and ChIP-PET data
(Loh et al., 2006) are summarized in Table S3.
We also validated predicted target loci by quantitative ChIP-
PCR using primer pairs specific to the predicted target loci that
are occupied by either multiple, or fewer, factors with various
MAT p values (see Experimental Procedures and Table S4) to
confirm that our target cutoff was appropriate to minimize false
positives. Most of target loci we tested for each factor show sub-
stantial enrichment over the BirA control (Figure S5). With these
results and additional quantitative PCR confirmation, we esti-
mate an average false positive rate of < 5%. These estimates
are comparable to those in previous studies in which antibodies
were employed (Boyer et al., 2006; Lee et al., 2006). While our
global dataset may miss some authentic targets due to our cutoff
criteria, few irrelevant loci are likely to be present.
Among the 6632 targets bound in aggregate by the nine
factors, 50% are occupied by only one of the nine factors
Figure 3. Summary of Nine Transcription Factor Occupancy and Histone Modification Status
(A) Number of target promoters bound by each factor or associated with H3K4 or H3K27 trimethylation.
(B) Relative position of chromosomal target loci of each factor to the TSS.
(C) Number of common targets of multiple factors. y axis represents the number of target promoters occupied by transcription factor(s). Red dots represent the
accumulated number of target promoters.
(D) Predicted consensus binding motif of multiple factor target loci using MEME.
(E) Correlation between each factor targets and hierarchical cluster of nine factors based on their target similarity.(Figure 3C). Clustering of the nine transcription factors based on
their target correlations (Figure 3E) shows that of the nine tested
factors, Nanog, Sox2, Dax1, Nac1, Oct4, Klf4, and Zfp281 ex-
hibit overall similarity in their targets. In contrast, targets of
Myc and Rex1 segregate to a distinct cluster (Figure 3E, cluster).
Functional classification of the presumptive targets of each fac-
tor using the PANTHER classification tool also demonstrates
separation of factors in two classes (Mi et al., 2007). In general,
target genes of each of the tested factors are enriched in genes
involved in nucleic acid metabolism and transcriptional control.
Interestingly, targets of Myc or Rex1 are implicated in protein
metabolism, rather than in developmental processes, whereastargets of the other factors are enriched in genes for develop-
mental processes (Figure S6).
Histone Modification Signatures
Core pluripotency factors are involved in both gene activation
and repression in ES cells (Boyer et al., 2005; Loh et al., 2006).
Mechanisms that account for this differential regulation are not
understood. To address this question, we performed supervised
clustering (Figure 4A, see Experimental Procedures) to reveal
the relationship, if any, between targets of various combinations
of transcription factors and corresponding H3K4me3 and
H3K27me3 marks, as well as gene expression profiles.Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc. 1053
Figure 4. H3K4me3 and H3K27me3 Status and Factor Occupancy of the Promoters
(A) A supervised cluster image showing 6632 target promoters occupied by different factor combinations (see Experimental Procedures). Corresponding
H3K4me3 (red) and H3K27me3 (blue) histone marks (presence: 1; absence: 0) as well as gene expression profiles (log2) upon J1 ES cell differentiation
(0–18 hr: red, 4–14 days: blue, see Experimental Procedures) are shown as moving window averaged lines (bin size 50 and step size 1). Bar ‘‘a’’ represents
the promoters occupied by multiple factors including at least Nanog, Sox2, Dax1, Nac1, and Oct4 (left panel) and corresponding gene expression changes
upon differentiation (middle panel) as well as their histone marks (right panel). Bars ‘‘b’’ represent the clusters of promoters occupied by a single factor Nanog,
Dax1, Klf4, and Zfp281, respectively (see Figure 5E and 5H). Green lines (bars ‘‘c’’) represent Myc target promoters with corresponding gene expression profiles
and histone mark status.
(B) H3K4me3 (red line) and H3K27me3 (blue line) status for Myc target promoters.
(C) Expression profiles of Myc target genes at different time points upon differentiation (0–18 hr: red, 4–14 days: blue). Total 6632 target genes of any of nine
factors are shown, and moving window average (bin size 50 and step size 1) was applied (B and C).
(D) Factor target promoters are both H3K4me3 and H3K27me3 rich over all promoters. ‘‘7TFs’’ represent the targets of any of seven factors (Nanog, Sox2, Dax1,
Nac1, Oct4, Klf4, and Zfp281), and ‘‘All’’ represents all promoters. Asterisk indicates hypergeometric probability < 0.0001.
(E) Histone marks on the target promoters of each factor. Asterisk indicates hypergeometric probability < 0.0001.The H3K4me3 and H4K27me3 marks of Myc target promoters
exhibit a unique distribution in comparison with promoters bound
by the other factors (Figure 4A, green bars c). 96% and 5% of Myc
target promoters bear H3K4me3 and H3K27me3, respectively
(Figure 4B). A previous study suggested a relationship between
Myc occupancy and various histone marks (Guccione et al.,
2006). Our data confirm this observation on a genome-wide
scale, and establish the correlation within ES cells. As anticipated
by these histone marks, Myc target genes are more frequently
expressed as compared with targets of other factors in ES cells
(Figure 4C). Our findings provide evidence that Myc occupancy1054 Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc.is associated with large-scale, global alteration of chromatin at
Myc targets, and that such effects are qualitatively different
from those associated with the core pluripotency factors.
To pursue these correlations, we examined the relationship of
the target promoters of seven factors with the H3K4me3 and
H3K27me3 marks. We removed Myc and Rex1 from this analysis,
because the predicted targets of these factors reveal functional
segregation. Interestingly, the predicted target promoters are
enriched overall in both H3K4me3 and H3K27me3 marks as
compared with all promoters (58% and 26% respectively, Fig-
ure 4D). However, closer examination of the correlation of targets
of individual factors with these histone marks reveals three differ-
ent classes (Figure 4E). Target promoters of Nanog, Sox2, Dax1,
Oct4, and Klf4 bear enriched marks for both H3K4me3 and
H3K27me3.However,predicted targets of Zfp281 showconsider-
able enrichment for the repressive H3K27me3 mark, consistent
with a role of Zfp281 in gene repression. Similar to target pro-
moters of Myc, Rex1 and Nac1 targets show less H3K27me3
marks, indicating possible rolesof these factors ingene activation.
Recent data with hES cells showed that most H3K27me3
marks overlap H3K4me3 marks (Pan et al., 2007; Zhao et al.,
2007). We have observed somewhat less extensive overlap as
35% of H3K27me3 marks (725 among 2046) overlap with
H3K4me3 marks. The apparent quantitative difference relates
to the threshold level used in assigning target genes. As we
reduce the stringency of target selection, we observe a 39% in-
crease in genes with H3K27me3 marks (2046 to 2843). Bivalent
signatures increased 138% (725 to 1729) and 61% of H3K27me3
marks then lie within H3K4me3 marks on the promoters. Our
results are in accord with the prior observation that H3K27me3
signals are in general weaker than H3K4me3 signals (Pan
et al., 2007; Zhao et al., 2007).
Previously identified clusters of gene promoters devoid of
H3K4me3 and H3K27me3 marks on their promoters in hES cells
(Guenther et al., 2007; Zhao et al., 2007) are also not bound by
any of nine factors we tested (Figure S7). Presumably, the mech-
anism of repression is unique, as H3K27 methylation is one of the
principal histone modification marks associated with gene
repression.
Regulation of Target Gene Expression
by Transcription Factor Occupancy
A striking observation emerges from supervised clustering anal-
ysis in considering potential mechanisms that might account for
differential regulation of transcription factor targets in ES cells.
The genes whose promoters are occupied targets by multiple
factors, including Nanog, Sox2, Dax1, Nac1, Oct4, and Klf4,
are generally active in ES cells, and repressed upon differentia-
tion (Figure 4A, bar a and Figure S8). On the other hand, the clus-
ters of genes that are inactive or repressed in ES cells, but are
expressed upon differentiation, are comprised largely of those
gene promoters bound by a single factor (for example, Nanog,
Dax1, Klf4, or Zfp281) as shown in Figure 4A, bars b. This obser-
vation suggests that the roles of the pluripotency factors are
sensitive to their immediate context. A single factor may bind
to targets that are ‘‘poised’’ and inactive, or may act to repress
its targets, presumably in association with corepression com-
plexes, whereas it may participate in gene activation when
bound to a promoter region in concert with other pluripotency
regulators. Prior protein network analysis revealed multiple con-
nections between several core factors and repressive chromatin
remodeling complexes, including NuRD and Polycomb (PRC1)
(Wang et al., 2006).
To pursue this observation, we classified target genes based
on the co-occupancy of transcription factors on their promoters.
Since Myc and Rex1 have distinct sets of targets (Figures 3E and
4A), we focused on six other factors for further analysis (Nanog,
Sox2, Dax1, Nac1, Oct4 and Klf4; Zfp281 was excluded due to
less target gene overlap). We observed significant differencesbetween common targets of all 6 factors and targets of single fac-
tors in their gene expression profiles, as revealed by gene set en-
richment analysis (GSEA) (Subramanian et al., 2005) (Figures 5A–
5E). The majority of common targets of six factors are highly active
(Figure 5A). Among targets bound by fewer factors, both active
and repressed genes are nearly balanced (Figures 5C and S8).
Targets occupied by any single factor were predominantly inac-
tive or repressed in ES cells (Figure 5D) and this is even more ap-
parent with the targets of Nanog, Dax1,Klf4, and Zfp281as shown
in Figure 4A, bars b (Figure 5E, 1TF*). The relationship between
target promoter occupancy and gene expression level is in excel-
lent accordance with the observed histone marks. The common
target promoters of 6 factors show an 80% increase of the
H3K4me3 signature and a 60% decrease of H3K27me3 sig-
nature, as compared to all promoters. On the other hand, unique
targets of only one factor exhibited an increased level of
the H3K27me3 signature (Figure 5H, 1TF and 1TF*).
Our findings argue that pluripotency factors act in a highly
combinatorial fashion to activate or maintain expression of a sub-
set of target genes, while they are inactive or function more often
to repress genes when acting alone, or with only one or few other
factors. Distinguishing the ‘‘on’’-‘‘off’’ state of targets based on
the extent of promoter occupancy may provide a mechanism
by which a relatively small set of factors controls two comple-
mentary aspects of transcription required for maintenance of
pluripotency. While pluripotency factors hold differentiation-pro-
moting genes in check, they must also function together to drive
expression of genes encoding proteins required for self-renewal.
In accord with this interpretation, the predicted targets of
multiple factors and single factors differ in gene ontology (GO)
categories (Figures 5I and 5J). The six factor common target
genes are implicated more frequently in developmental pro-
cesses than targets occupied by fewer factors. The enrichment
for genes involved in developmental processes is correlated
positively with the number of bound factors from 3–6 (Figure 5I).
Furthermore, we tested roles of each factor in their target gene
regulation to determine if any single factor is more associated
with either gene activation or repression. Surprisingly, except
for Myc and Rex1, all the remaining factors occupy promoters
of both nonexpressed and expressed genes (Figure S9). An ex-
ample is shown in Figure 5F. Among all Nanog target promoters,
genes are roughly equally expressed or repressed, whereas
among Nanog-only targets, genes are predominantly inactivated
or repressed (Figure 5G). This observation is common to all the
other factors, except Myc and Rex1 (Figure S10).
Expansion of Core Transcriptional Regulatory
Network in ES Cells
Previous studies suggested that transcription factors in ES cells
participate in several transcriptional regulatory circuits, including
autoregulation, feed-forward regulation and interconnectivity
(Boyer et al., 2005). To explore this further, we visualized tran-
scriptional interconnectivity of the nine factors we tested (Fig-
ure 6A). Our data describe highly intertwined, complex regulatory
circuits exhibiting all three regulatory mechanisms. In addition to
autoregulatory mechanisms involving Nanog, Oct4, and Sox2, we
observe that Dax1 and Klf4 also display potential autoregulatory
loops. Among these five genes, Nanog, Oct4, Sox2, and Dax1 areCell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc. 1055
target hubs of at least 4 of the nine tested factors (and four of six
factors: Nanog, Sox2, Dax1, Nac1, Oct4, and Klf4).
Combining transcription regulatory networks and protein in-
teraction networks facilitates a comprehensive understanding
of differential gene expression regulation in complex genomes
(Walhout, 2006). We asked if the interconnectivity of nine factors
might be useful to expand the core transcriptional network by
combining target data with protein-protein interaction data. We
merged our transcriptional regulatory network with the protein
interaction network we previously reported (Figure 6B) (Wang
et al., 2006). The initial protein network is comprised 35 proteins,
the majority of which are essential to pluripotency and/or early
development. Surprisingly, promoters of 77% of the protein net-
work genes are occupied by at least one of the nine factors
tested (27 of 35, p value < 2.4 3 107). Eleven of 35 genes are
Figure 5. Target Gene Expression and
Transcription Factor Occupancy on Their
Target Promoters
(A–E) GSEA analyses showing the relationship
between target gene expression and factor occu-
pancy. Target promoters were classified based on
the number of co-occupying factors and corre-
sponding gene expression upon differentiation
was tested. Common targets of six factors (A)
are enriched in active genes in ES cells, whereas
single-factor only targets are more repressed. (D)
‘‘1TF*’’ represents a subset of ‘‘1TF,’’ which
includes promoters solely occupied by either
Nanog, Dax1, Klf4, or Zfp281 as described in
Figure 4A, bars ‘‘b’’ (E).
(F and G) Nanog targets are both active and
repressed in ES cells (F), however targets only
occupied by Nanog are repressed (G).
(H) Common target promoters of six factors
(Nanog, Sox2, Dax1, Nac1, Oct4, and Klf4) are
enriched for H3K4me3 marks and reduced for
H3K27me3 marks. Promoters occupied by only
one factor show an increase in H3K27me3 marks
(1TF and 1TF*). Double asterisk indicates hyper-
geometric probability < 0.0001, and single asterisk
indicates hypergeometric probability = 0.006.
(I and J) Genes of multiple factor targets (at least
4TFs) are enriched in developmental processes.
Percentages of gene hit against total number of
genes are indicated on the y axis, and actual num-
bers of genes are also shown (hit/total).
occupied by at least four factors (of any
nine factors, p value < 9.1 3 108). Nine
of 35 are occupied by at least 4 of 6 fac-
tors (Nanog, Sox2, Dax1, Nac1, Oct4,
and Klf4, p value < 5.3 3 108). In
Figure 6B, target interactions are de-
picted with the size of each circle reflect-
ing the degree of factor co-occupancy of
the promoter of the gene encoding each
factor. In this manner, we identify addi-
tional target hubs (by four of nine factors),
including Dax1, Rest, Rif1, Rex1, Sall4,
Rybp, Sall1, Ewsr1, and SP1 within the in-
teractome, in addition to previously accepted target hubs
(Nanog, Oct4, and Sox2) (Figure 6B). Independent evidence
demonstrating the importance of several of these factors (Sall4
[Sakaki-Yumoto et al., 2006; Zhang et al., 2006], Rif1 [Loh
et al., 2006], Rybp [Pirity et al., 2005]) in maintaining pluripotency
is consistent with this network architecture. Taken together, our
data reveal that the actual core factor set in ES cells is larger and
more highly interconnected than previously suspected (Loh
et al., 2006; Wang et al., 2006; Zhang et al., 2006).
In addition to the target hubs within the network, we have iden-
tified many additional targets of multiple factors. These targets
are highly likely to be important in self-renewal and lineage com-
mitment (Jeong et al., 2001). Table 1 lists DNA-binding (or chro-
matin-associated) proteins whose promoters are occupied by
multiple factors (at least five of six factors, Nanog, Dax1, Sox2,1056 Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc.
Figure 6. Expanded Transcriptional Regulatory Network and Regulatory Circuit within Four Somatic Cell Reprogramming Factors and
Nanog
(A) Transcriptional regulatory circuit within nine factors. Five factors (Nanog, Oct4, Sox2, Dax1, and Klf4) show autoregulatory mechanism.
(B) Expanded transcriptional regulatory network showing target hubs of multiple factors within the previously identified protein interaction network. Yellow circles
represent nine factors examined. The size of each circle reflects the degree of factor co-occupancy. Arrowhead indicates the direction of transcriptional regu-
lation (A–C). Sox2, Klf4, and Myc were not in the original protein interaction network (Wang et al., 2006).
(C) Transcriptional regulatory circuit within four somatic cell reprogramming factors and Nanog.Nac1, Oct4, and Klf4). The predicted targets encode a set of pro-
teins involved in regulation of development decisions, signaling
pathways, and chromatin remodeling. Although functional as-
sessment is necessary to determine the roles of many of these
proteins in pluripotency and self-renewal, validation of several
target genes (Nanog, Oct4, Rest, Sall4, Sox2, Rex1) and identi-
fication of several others within the protein interaction network
(Wang et al., 2006) make it highly likely that many others in this
set will be shown subsequently to be functionally relevant. More-
over, among targets encoding non-DNA associated proteins,
many are important in an ES cell context, including Tcl1, which
participates in the PI3K/Akt signaling pathway and promotes
ES cell proliferation (Ivanova et al., 2006); Il6st (gp130), which
is involved in the LIF/STAT3 pathway (Ernst et al., 1996; Yoshida
et al., 1994); and Bmp4, a critical signaling molecule for early
differentiation and ES cells. Indeed, Fbxo15, the locus first em-
ployed as a marker for somatic reprogramming (Takahashi and
Yamanaka, 2006), is also a multifactor target gene.
Regulatory Network within Four Somatic Cell
Reprogramming Factors
Fibroblasts of either mouse or human origin can be reprog-
rammed to a pluripotent ES-like state (iPS cells) upon forced ex-
pression of three or four (or more) factors, including Klf4, Oct4,
Sox2, Nanog, and c-Myc (Park et al., 2007; Takahashi et al.,2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007b;
Yu et al., 2007). iPS cells appear highly similar to conventional
ES cells. The regulatory relationships among the reprogramming
factors are, therefore, of particular interest in accounting for the
potency of this cocktail of factors. The transcriptional hierarchy
within the original 4 reprogramming factors is depicted in Fig-
ure 6C. In addition to previously identified feed-forward regula-
tion within Oct4, Sox2, and Nanog, our results argue that Klf4
is an upstream regulator of larger feed-forward loops containing
Oct4, Sox2, and other common downstream targets, such as
Nanog, and also occupies the c-Myc promoter. In addition to
the histone marks of Myc targets (discussed above), our findings
from target categorization and the predicted regulatory network
also support distinct functions of Myc in ES cells. These func-
tions are likely to include positive regulation of proliferation, neg-
ative regulation of differentiation, and regulation of chromosomal
accessibility of other factors, as previously suggested (Niwa,
2007). The findings described above regarding histone marks
associated with Myc occupancy provide experimental evidence
in support of these inferences.
DISCUSSION
Here, we demonstrate the utility of in vivo biotinylation of tagged
proteins and streptavidin affinity capture to identify globalCell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc. 1057
Table 1. Examples of DNA Binding Proteins that Are Common
Targets of Multiple Transcription Factors: At Least Five of Six
Factors, Nanog, Dax1, Sox2, Nac1, Oct4, and Klf4
Symbol Accession Number Gene Name
6030445D17Rik NM_177079 Riken cDNA 6030445d17 gene
Ankrd10 NM_133971 Ankyrin repeat domain 10
Asxl1 NM_001039939 Additional sex combs like 1
(drosophila)
Cbx1 NM_007622 Chromobox homolog 1
(drosophila hp1 beta)
Cbx7 NM_144811 Chromobox homolog 7
Cdx1 NM_009880 Caudal type homeo box 1
Chd9 NM_177224 Chromodomain helicase dna
binding protein 9
Dido1 NM_175551 Death inducer-obliterator 1
E2f4 NM_148952 E2F transcription factor 4
Evx1 NM_007966 Even skipped homeotic gene 1
homolog
Fubp3 NM_001033389 Far upstream element (fuse)
binding protein 3
Gbx2 NM_010262 Gastrulation brain homeobox 1
Grhl3 NM_001013756 Grainyhead-like 3 (drosophila)
H2afx NM_010436 H2A histone family, member x
Hist1h2an NM_178184 Hypothetical protein
1190022l06
Hist1h3i NM_178207 Histone 1, h3g
Hnrpdl NM_016690 Heterogeneous nuclear
ribonucleoprotein d-like
Hoxb13 NM_008267 Homeo box b13
Jarid2 NM_021878 Jumonji, at rich interactive
domain 2
Klf2 NM_008452 Kruppel-like factor 2 (lung)
Klf9 NM_010638 Kruppel-like factor 9
Max NM_008558 Max protein
Mllt6 NM_139311 Myeloid/lymphoid or mixed
lineage-leukemia translocation
to 6 homolog (drosophila)
Msh6 NM_010830 Muts homolog 6 (e. coli)
Msx2 NM_013601 Homeo box, msh-like 2
Mybl2 NM_008652 Myeloblastosis oncogene-like 2
Myst2 NM_177619 Myst histone acetyltransferase 2
Mzf1 NM_145819 Myeloid zinc finger 1
Nanog NM_028016 Nanog homeobox
Nkx2-2 NM_010919 Nk2 transcription factor related,
locus 2 (drosophila)
Otx2 NM_144841 Orthodenticle homolog 2
(drosophila)
Pax6 NM_013627 Paired box gene 6
Phc1 NM_007905 Polyhomeotic-like 1 (drosophila)
Pou5f1 NM_013633 Pou domain, class 5,
transcription factor 1
Rarg NM_001042727 Retinoic acid receptor, gamma
Rax NM_013833 Retina and anterior neural fold
homeobox1058 Cell 132, 1049–1061, March 21, 2008 ª2008 Elsevier Inc.targets of multiple factors involved in the transcriptional control
of pluripotency in ES cells. Our approach provides a degree of
consistency in the experimental platform generally not attainable
in ChIP-Chip experiments that rely on diverse antibodies of un-
known specificity and sensitivity. We suggest that the bioChIP-
Chip method may serve as a useful tool for assessing the quality
of native antibodies, given that there is no simple a priori method
for determining the suitability of a given antibody for ChIP proce-
dures. As cell lines expressing tagged proteins may also be em-
ployed to study protein-protein interactions, the generation of
two independent data-rich resources can be achieved with a
single cell line ‘‘reagent’’ and similar procedures.
Our studies not only suggest a more comprehensive and com-
plex view of the pluripotency network in ES cells than prior work
(Boyer et al., 2005; Loh et al., 2006), but also provide additional
insights into specific regulatory features and an extensive data-
base for further exploration. First, by mapping promoter occu-
pancy of nine factors, including the original four somatic cell
reprogramming factors, we have uncovered remarkable combi-
natorial binding at many targets: 800 gene promoters are bound
by four or more transcription factors of those tested (Figure 3C).
Table 1. Continued
Symbol Accession Number Gene Name
Rbbp5 NM_172517 Riken cDNA 4933411j24 gene
Rest NM_011263 Re1-silencing transcription
factor
Rnf12 NM_011276 Ring finger protein 12
Sall4 NM_175303 Testis expressed gene 20
Sox13 NM_011439 Sry-box containing gene 13
Sox2 NM_011443 Sry-box containing gene 2
Spic NM_011461 Spi-c transcription factor (spi-1/
pu.1 related)
T NM_009309 Brachyury
Tbx3 NM_198052 T-box 3
Tcea3 NM_011542 Transcription elongation factor
a (sii), 3
Tcfap2c NM_009335 Transcription factor ap-2,
gamma
Tcfcp2l1 NM_023755 Riken cDNA 4932442m07 gene
Tgif NM_009372 TG interacting factor
Trib3 NM_144554 Induced in fatty liver dystrophy 2
Trib3 NM_175093 Induced in fatty liver dystrophy 2
Trp53bp1 NM_013735 Transformation related protein
53 binding protein 1
Zfp13 NM_011747 Zinc finger protein 13
Zfp206 NM_001033425 Zinc finger protein 206
Zfp36l1 NM_007564 Zinc finger protein 36,
c3h type-like 1
Zfp42 NM_009556 Zinc finger protein 42
Zfp704 NM_133218 Zinc finger protein 704
Zic2 NM_009574 Zic finger protein of the
cerebellum 2
Zic5 NM_022987 Zinc finger protein of the
cerebellum 5
Second, whereas numerous targets are shared by an extended
set of pluripotency factors (Oct4, Sox2, Nanog, Klf4, Dax1,
Zfp281, and Nac1), the targets of c-Myc (and also Rex1) largely
fall into a different cluster (Figures 3E and 4A). Third, we have
discovered a striking correlation between the number of bound
factors and the likelihood that a target gene is expressed in
wild-type ES cells and then repressed on differentiation (Figures
4A and 5). These observations provide a means for direct in-
volvement of these factors in promoting self-renewal by activat-
ing expression of those genes (including the pluripotency factors
themselves) and simultaneously inhibiting expression of differen-
tiation-promoting genes. One possibility is that the pluripotency
factors individually serve as weak activators, and that multi-fac-
tor binding augments activator function. A priori, the converse
situation might have applied; that is, multifactor binding would
predominantly be associated with repression. Despite the pres-
ence of pluripotency factors in protein complexes with corepres-
sor components (Wang et al., 2006), our findings are inconsistent
with this possibility. Another notable observation regarding his-
tone marks is that the Polycomb targets are largely different
from common targets of multiple core transcription factors. We
demonstrate that common targets of multiple factors are active
in ES cells and their histone marks show distinct patterns (Fig-
ure 5H). Fourth, by combining target promoter occupancy data
with our prior protein interaction network, we identified addi-
tional regulatory hubs, defined as those gene promoters bound
by multiple factors (Figure 6B). These new hubs include Sall4,
Rif1, Rest, and Dax1, all of which have been shown to be impor-
tant for ES cell properties in independent studies. Fifth, our stud-
ies suggest a hierarchy within the four somatic reprogramming
factors, such that Klf4 serves as an upstream regulator of
feed-forward circuits involving Oct4 and Sox2, as well as more
downstream effectors (e.g., Nanog), and is predicted to regulate
c-Myc based on promoter occupancy (Figure 6C).
In addition to the inferences gained regarding the pluripotency
factors themselves, our data provide insight into how c-Myc dif-
fers from these core factors in regulating its targets. In addition to
sharing few targets, c-Myc occupancy is associated with striking
differences in associated histone marks (Figures 4A, 4B, and 4E),
and with enrichment for expressed genes (Figure 4C). These
findings are consistent with the view that c-Myc occupancy is
associated with broad changes in chromatin accessibility. This
unique target regulation by Myc may account for its capacity
to enhance reprogramming, while also being dispensable as
an exogenous factor (Nakagawa et al., 2007; Wernig et al.,
2007a).
The discovery of a class of predicted targets bound by multiple
(>4) pluripotency transcription factors (Figures 4A, 5A, and 5B
and Table 1) is of interest as these genes are largely expressed
in ES cells and repressed on differentiation. As this class in-
cludes several genes within the protein interaction network
(e.g., Nanog, Oct4, Rest, Sall4, Sox2), it is likely that additional
genes within this set, that have not as yet been evaluated for
potential roles in ES cells, will prove critical to the maintenance
of pluripotency. The recognition that human skin cells can be re-
programmed to iPS cells with the same factors that are active in
mouse cells (Park et al., 2007; Takahashi et al., 2007; Yu et al.,
2007) provides strong evidence in favor of common networksin pluripotent mouse and human cells, despite differences in
the growth factor requirements and behavior of cultured mouse
and human ES cells. Our data constitute a framework for further
exploration of the complex transcriptional network dedicated to
establishment and preservation of pluripotency.
EXPERIMENTAL PROCEDURES
ES Cell Lines and Culture
Mouse J1 ES cell lines were maintained in ES medium as described previously
(Wang et al., 2006). Briefly, cells were maintained in ES medium (DMEM;
Dulbecco’s modified Eagle’s medium) supplemented with 15% fetal calf
serum, 0.1 mM b-mercaptoethanol, 2 mM L-glutamine, 0.1 mM nonessential
amino acid, 1% of nucleoside mix (1003 stock, Sigma), 1000 U/ml recombinant
leukemia inhibitory factor (LIF; Chemicon) and 50 U/ml Penicillin/Streptomycin.
Further details are documented in Supplemental Data.
Chromatin Immunoprecipitation and Antibodies
ChIP reactions and bioChIP reactions were performed as described previously
with minor modifications (Kim et al., 2005). For bioChIP reactions, streptavidin
beads (Dynabeads MyOne Streptavidin T1) were used to precipitate chroma-
tin, and 2% SDS was applied for one of the washing steps. Further details are
described in Supplemental Data. At least three biological replicates were
performed in each case. Detailed procedure, list of antibodies, list of primers
used for ChIP-PCR validation are available in Supplemental Data.
Microarray and Data Processing
Ligation-mediated PCR was performed to amplify ChIP samples as described
previously (Ren et al., 2000). Microarray hybridizations were performed on the
Affymetrix GeneChip Mouse promoter 1.0R arrays and Model-based Analysis
of Tiling-array (MAT) was applied to predict the target loci (Johnson et al.,
2006). Further details are available in Supplemental Data.
Histone Modification Signatures
The significance of enrichment or depletion of H3K4me3 or H3K27me3 signa-
ture on the promoters occupied by each factor (Figure 4E) or multiple factors
(Figure 4D and Figure 5H) was evaluated by hypergeometric distribution test
(asterisk or double asterisk).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, ten
figures, one table, Supplemental References, and three Excel spreadsheets
and can be found with this article online at http://www.cell.com/cgi/content/
full/132/6/1049/DC1/.
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